Your browser doesn't support javascript.
loading
A real-world retrospective study of safety, efficacy, compliance and cost of combination treatment with rush immunotherapy plus one dose of pretreatment anti-IgE in Chinese children with respiratory allergies.
Zhang, Pingping; Bian, Sainan; Wang, Xibin; Chen, Zhuanggui; Yang, Lifen; Xiao, Feng; Guan, Kai.
Afiliação
  • Zhang P; Department of Pediatrics, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Bian S; Department of Allergy, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Wang X; Department of Allergy, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • Chen Z; Department of Pediatrics, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Yang L; Department of Pediatrics, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Xiao F; Department of Allergy, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Guan K; Department of Pediatrics, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Front Immunol ; 13: 1024319, 2022.
Article em En | MEDLINE | ID: mdl-36268011
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Rinite Alérgica Tipo de estudo: Etiology_studies / Health_economic_evaluation / Observational_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Asia Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Rinite Alérgica Tipo de estudo: Etiology_studies / Health_economic_evaluation / Observational_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Asia Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China